Edition:
United States

China NT Pharma Group Co Ltd (1011.HK)

1011.HK on Hong Kong Stock

1.74HKD
3:57am EDT
Change (% chg)

HK$-0.01 (-0.57%)
Prev Close
HK$1.75
Open
HK$1.75
Day's High
HK$1.75
Day's Low
HK$1.72
Volume
1,241,500
Avg. Vol
1,921,095
52-wk High
HK$2.40
52-wk Low
HK$1.27

Latest Key Developments (Source: Significant Developments)

China NT Pharma says FY net profit RMB 116.2 mln
Tuesday, 21 Mar 2017 06:30pm EDT 

China Nt Pharma Group Co Ltd <1011.HK>: Board recommended a final dividend of hk2.5 cents per share . Group reported a net profit of rmb116.2 million for year ended 31 december 2016, as compared with a net profit of rmb87.7 million .Overall revenue of the group for the year ended 31 december 2016 increased by rmb67.4 million or 7.9% to rmb915.1 million.  Full Article

China Nt Pharma obtains certification from China Food and Drug Administration
Thursday, 2 Mar 2017 11:16pm EST 

China Nt Pharma Group Co Ltd <1011.HK>: Jiangsu NT Biopharma successfully obtained new good manufacturing practices certification from China Food and Drug Administration .Estimated that production line can commence production of "Xi Di Ke" in March and sales will officially commence in April.  Full Article

China NT Pharma says co entered into asset purchase agreement with Novartis<1011.HK>
Wednesday, 18 May 2016 10:39am EDT 

China NT Pharma Group Co Ltd <1011.HK>: NT Pharma (as purchaser) entered into asset purchase agreement with Novartis . Purchase price would be in the aggregate sum of US$145 million . Co has made an application for the resumption of trading in the shares of co with effect from 9:00 a.m. on Thursday, 19 May 2016 .  Full Article

China NT Pharma says trading halted pending release of announcement regarding signed agreements of acquisition<1011.HK>
Wednesday, 18 May 2016 12:39am EDT 

China NT Pharma Group Co Ltd <1011.HK>: Trading halt . Seeks trading halt pending release of announcement in relation to signed agreements of acquisition of pharmaceutical assets .  Full Article

China NT Pharma Group Co Ltd says in discussions regarding acquisition of pharmaceutical assets
Tuesday, 5 Apr 2016 12:03am EDT 

China NT Pharma Group Co Ltd:Voluntary announcement potential acquisition.Company is in discussions with an independent third party regarding the potential acquisition of pharmaceutical assets.Company has not entered into any definitive agreement in relation to the potential acquisition.As at date of announcement, no material terms concerning potential acquisition have been agreed.  Full Article

China NT Pharma Group Co Ltd says completion of placing of new shares
Tuesday, 7 Jul 2015 06:06am EDT 

China NT Pharma Group Co Ltd:Says conditions set out in Placing Agreement have been fulfilled and Placing Completion took place on July 07 with an aggregate of 179,650,000 Placing Shares having been successfully placed to not less than six Placees at the Placing Price of HK$1.86 per Placing Share.Says conditions set out in the Subscription Agreement have been fulfilled and Subscription Completion took place on July 07 with 80,000,000 Subscription Shares having been allotted and issued to Subscriber at the Subscription Price which is equivalent to the Placing Price.Gross proceeds of the Placing and the Subscription are approximately HK$482.95 million and the net proceeds of the Placing and the Subscriptions (after deduction of relevant expenses) are approximately HK$476.68 million.  Full Article

More From Around the Web

BRIEF-China Nt Pharma obtains certification from China Food and Drug Administration

* Jiangsu NT Biopharma successfully obtained new good manufacturing practices certification from China Food and Drug Administration